Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Shuki Oya"'
Autor:
Shuki Oya, Hidetoshi Ozawa, Takayuki Nakamura, Yoshimi Maehiro, Yusuke Takaki, Yoshinobu Fukuyama, Yoshitaka Yamasaki, Maki Yamaguchi, Kazutoshi Aoyama, Fumihiko Mouri, Koji Nagafuji
Publikováno v:
HemaSphere, Vol 7, p e53072ea (2023)
Externí odkaz:
https://doaj.org/article/66b41367bcc84ceea53108b134a79bc7
Publikováno v:
Int. Journal of Clinical Pharmacology and Therapeutics. 60:52-56
Objective To report a case of drug-induced immune hemolytic anemia (DIIHA) that was suspected to have been caused by cefmetazole. Case summary A 93-year-old woman with no previous history of liver complications underwent a contrast-enhanced computed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d0ff95f4f7fdc56b62dfcfea3ab3652
https://doi.org/10.5414/cp204095
https://doi.org/10.5414/cp204095
Autor:
Shuki Oya, Hidetoshi Ozawa, Yoshimi Maehiro, Takayuki Nakamura, Yusuke Takaki, Toshinobu Fukuyama, Yoshitaka Yamasaki, Maki Yamaguchi, Kazutoshi Aoyama, Fumihiko Mouri, Koji Nagafuji
Publikováno v:
Leukemia Research. 130:107313
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7fc7083f413850af2fcab38180d45e24
https://doi.org/10.1016/j.leukres.2023.107313
https://doi.org/10.1016/j.leukres.2023.107313
Autor:
Kazutoshi, Aoyama, Yoshitaka, Yamasaki, Fumihiko, Mouri, Yoshimi, Maehiro, Yusuke, Takaki, Shuki, Oya, Takayuki, Nakamura, Satoshi, Morishige, Maki, Yamaguchi, Koji, Nagafuji
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 63(7)
FMS-like tyrosine kinase 3 (FLT3) inhibitors improve the prognosis of FLT3-internal tandem duplication (ITD)-positive acute myeloid leukemia (AML). Case 1 is a 47-year-old male patient who presented with a white blood cell count (WBC) of 95,700/ml wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::79199bdc5c3973c30e7cc4c7d2432555
https://pubmed.ncbi.nlm.nih.gov/35922945
https://pubmed.ncbi.nlm.nih.gov/35922945
Autor:
Kazutoshi Aoyama, Koichi Osaki, Kenta Murotani, Yoshitaka Yamasaki, Takuro Imai, Takayuki Nakamura, Maki Yamaguchi, Yusuke Takagi, Takuma Hazama, Shuki Oya, Fumihiko Mouri, Koji Nagafuji, Koichi Egashira, Satoshi Morishige
Publikováno v:
Journal of Hematopoietic Cell Transplantation. 10:129-135
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::28304c4b6e11ed40d0447a2cb798ec75
https://doi.org/10.7889/hct-20-022
https://doi.org/10.7889/hct-20-022
Autor:
Shuki Oya, Hidetoshi Ozawa, Takayuki Nakamura, Toshinobu Fukuyama, Yusuke Takaki, Yoshitaka Yamasaki, Kazutoshi Aoyama, Maki Yamaguchi, Fumihiko Mouri, Koji Nagafuji
Publikováno v:
Blood. 140:11784-11785
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ae834e40ed8a45c65ab58ec691bd118
https://doi.org/10.1182/blood-2022-165800
https://doi.org/10.1182/blood-2022-165800
Autor:
Satoshi, Morishige, Yoshitaka, Yamasaki, Shuki, Oya, Takayuki, Nakamura, Maki, Yamaguchi, Kazutoshi, Aoyama, Fumihiko, Mouri, Yasuko, Mizushima, Osamu, Nakashima, Koji, Nagafuji
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 63(4)
Inotuzumab ozogamicin (InO) was administered in three cases of relapsed/refractory adult acute lymphoblastic leukemia (ALL) before allogeneic hematopoietic stem cell transplantation (allo-SCT). One case developed extremely severe sinusoidal obstructi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4da99a7d5862ebcf36b61e56a7726868
https://pubmed.ncbi.nlm.nih.gov/35491216
https://pubmed.ncbi.nlm.nih.gov/35491216
Autor:
Kazutoshi Aoyama, Ritsuko Seki, Kensuke Sasaki, Yoshitaka Yamasaki, Takahiro Maeda, Takayuki Nakamura, Shuki Oya, Hidetoshi Ozawa, Yuichiro Semba, Koji Nagafuji, Fumihiko Mouri, Koichi Osaki, Toshihiro Miyamoto, Satoshi Morishige
Publikováno v:
International Journal of Hematology. 113:285-289
BCR-ABL1-like acute lymphoblastic leukemia (ALL) is a neoplasm of lymphoblasts committed to the B-cell lineage that lack the BCR-ABL1 translocation but show a pattern of gene expression very similar to that seen in ALL with BCR-ABL1 with poor prognos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f39f5815324cbf616ccdd1a09e1ad211
https://doi.org/10.1007/s12185-020-03006-5
https://doi.org/10.1007/s12185-020-03006-5
Autor:
Fumihiko Mouri, Koichi Osaki, Koji Nagafuji, Ritsuko Seki, Kenji Kuboyama, Takayuki Nakamura, Shuki Oya, Kazutoshi Aoyama, Shinichi Mizuno, Maki Yamaguchi, Takashi Okamura, Hidetoshi Ozawa, Yoshitaka Yamasaki, Satoshi Morishige
Publikováno v:
Haemophilia. 26:826-833
Background Factor V (FV) deficiency is a monogenic inherited coagulation disorder considered to be an ideal indication for gene therapy. To investigate the possibility of therapeutic application of genome editing, we generated induced pluripotent ste
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b77f24e0ace7ba34eec32532038fc3f
https://doi.org/10.1111/hae.14104
https://doi.org/10.1111/hae.14104
Autor:
Ritsuko Seki, Koichi Osaki, Shuki Oya, Takayuki Nakamura, Fumiko Arakawa, Hiroshi Saruta, Marina Nishi, Maki Yamaguchi, Satoshi Morishige, Koichi Ohshima, Kazutoshi Aoyama, Yoshitaka Yamasaki, Fumihiko Mouri, Koji Nagafuji
Publikováno v:
International Journal of Hematology. 110:506-511
Allogeneic hematopoietic cell transplantation (allo-HSCT) is considered the curative treatment option in patients with aggressive adult T cell leukemia/lymphoma (ATLL), but the treatment of relapse after allo-HSCT remains a major challenge. We report
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::004b5457a9446d29b9b448242a745524
https://doi.org/10.1007/s12185-019-02675-1
https://doi.org/10.1007/s12185-019-02675-1